Mass Spectrometry

Carcinogen levels in hairdressers’ blood appear to be linked to number of coloring treatments

Our capacity to generate data is unsurpassed, but how do we cope with the data deluge? It’s time to embrace data-driven discovery in biology and medicine.

The development of mass spectrometry is one of science’s great technology stories.

While Bernard Kuster and his colleagues were compiling ProteomicsDB, a separate team of researchers at Johns Hopkins University, Baltimore, USA, and the Institute of Bioinformatics, Bangalore, India, tackled the challenge in a different way

In February 2001, scientists celebrated the initial sequencing of the human genome by two competing groups. Now, not one but two draft human proteomes form the next logical link in a chain.

When and where should we apply the concept of “just enough is best”?

What has driven spectroscopic techniques into their current prominent position in a plethora of application areas?

Highly specific enzymes for middle down approach - rapid mass spectrometric analysis of antibody based biotherapeutics using FabRICATOR®

New methods that focus on increased sensitivity or resolution are being developed on an almost daily basis. But are they the right methods and do we even need them? I say “no and no,” and here’s why.

How broad are the legal duties of analytical laboratories and what do recent developments in US law mean for labs around the world?